Yayın Ağı
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler
Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia: A single center experience
BONE MARROW TRANSPLANTATION
, cilt.57, sa.SUPPL 1, ss.125, 2022 (SCI-Expanded)
Use of venetoclax in combination with hypomethylating agents in patients with acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation
BONE MARROW TRANSPLANTATION
, cilt.57, sa.SUPPL 1, ss.335-336, 2022 (SCI-Expanded)
Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome
BONE MARROW TRANSPLANTATION
, cilt.57, sa.SUPPL 1, ss.206-207, 2022 (SCI-Expanded)
The efficacy and safety of second allogeneic hematopoietic stem cell transplantation.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.40, sa.16, 2022 (SCI-Expanded)
REPLY FROM THE AUTHORS
TURKISH JOURNAL OF HEMATOLOGY
, cilt.38, sa.4, ss.332, 2021 (SCI-Expanded)
Treatment of Thrombocytopenia after Allogeneic Stem Cell Transplantation with Eltrombopag
BONE MARROW TRANSPLANTATION
, cilt.55, sa.SUPPL 1, ss.410-411, 2020 (SCI-Expanded)
CD34+Cell Subsets in Stem Cell Products and Their Relationship with Engraftment Kinetics
BONE MARROW TRANSPLANTATION
, cilt.55, sa.SUPPL 1, ss.688-689, 2020 (SCI-Expanded)
The Influence of anti-thymocyte Globulin(ATG) on the Outcomes of Patients with AML W/wo Measurable Residual Disease(MRD) at the time of Unrelated Donor Transplantation
BONE MARROW TRANSPLANTATION
, cilt.55, sa.SUPPL 1, ss.204, 2020 (SCI-Expanded)
THE EFFECT OF PREDICTED INDIRECTLY RECOGNIZABLE HLA EPITOPES PRESENTED BY HLA-CLASS II MOLECULES ON 1 ANTIGEN/ALELLE MISMATCHED UNRELATED HSCT: A SINGLE CENTER EXPERIENCE
HLA
, cilt.93, sa.5, ss.368-369, 2019 (SCI-Expanded)
Retrospective analysis of 115 unselected patients with mantle cell lymphoma: Single center experience.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.36, sa.15, 2018 (SCI-Expanded)
Management and Outcome of Central Nervous System (CNS) Involvement in Acute Lymphoblastic Leukemia (ALL)
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
, cilt.23, sa.3, 2017 (SCI-Expanded)
A RANDOMIZED COMPARISON OF HEMOGLOBIN CONTENT-BASED VS STANDARD (UNIT-BASED) RBC TRANSFUSION POLICY EFFICIENCIES
VOX SANGUINIS
, cilt.101, ss.121, 2011 (SCI-Expanded)
CIRCULATING ENDOTHELIAL PROGENITOR CELLS (CEPCS) AFTER RECOMBINANT HUMAN GRANULOCYTE-COLONY STIMULATING FACTOR (RHG-CSF) IN HEALTHY DONORS
VOX SANGUINIS
, cilt.99, ss.504-505, 2010 (SCI-Expanded)
The profile of erythrocyte antigens after allogeneic hematopoietic stem cell transplantation
BONE MARROW TRANSPLANTATION
, cilt.29, 2002 (SCI-Expanded)
HLA-A1 is associated with CMV viremia in recipients of hematopoietic stem cell transplants from seropositive donors
TISSUE ANTIGENS
, cilt.59, ss.75-76, 2002 (SCI-Expanded)
Repopulation of liver endothelial cells, but not hepatocytes, by allogeneic hematopoietic cell transplants.
BLOOD
, cilt.98, sa.11, 2001 (SCI-Expanded)
The use of rhG-CSF for peripheral blood progenitor cell collection in healthy donors may induce the tissue factor dependent pathway.
BLOOD
, cilt.96, sa.11, 2000 (SCI-Expanded)
Diğer Dergilerde Yayınlanan Makaleler
Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar
ALPHA-1-ANTITRYPSIN EXPERIENCE FOR STEROID-RESISTANT ACUTE GRAFT-VERSUS-HOST DISEASE
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 Nisan 2023, ss.301-302
THE OUTCOME OF SECONDARY AML PATIENTS WITH PRIOR BREAST CANCER UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION IS AS GOOD AS DE NOVO AML
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 Nisan 2023, ss.181-182
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPS/REFRACTORY LYMPHOMA PATIENTS: A SINGLE CENTER EXPERIENCE
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 Nisan 2023, ss.457-458
A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in epatients with myeloproliferative neoplasm.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 - 31 Mayıs 2020, cilt.38
Safety and outcome of allogeneic stem cell transplantation in mycosis fungoides and Sezary syndrome: A seven-year tertiary center analysis.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 - 31 Mayıs 2020, cilt.38
Allogeneic hematopoietic stem cell transplantation for primary myelofibrosis: A single-center experience.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 - 31 Mayıs 2020, cilt.38
Splenic marginal zone lymphoma: Clinical characteristics and prognostic factors in a series of 52 patients
44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, ss.441
Is mobilization with chemotherapy effect response in the multiple myeloma?
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Almanya, 24 - 27 Mart 2019, cilt.54, ss.500
Haploidentical stem cell transplantation may be an option for hematological malignancies in urgent conditions
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Almanya, 24 - 27 Mart 2019, cilt.54, ss.382
Blood group incompatibility in haplo-identical stem cell transplantation: Favor or unfavorable effect on the erythrocyte recovery?
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Almanya, 24 - 27 Mart 2019, cilt.54, ss.368-369
Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT?
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Almanya, 24 - 27 Mart 2019, cilt.54, ss.505-506
Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic transplantation: Retrospective multicenter study of Turkish hematology research and education group (THREG), updated data
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Almanya, 24 - 27 Mart 2019, cilt.54, ss.254-255
Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37
Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37
Fit Elderly Patients with aggressive lymphoma do not need dose reduction of conditioning regimen
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portekiz, 18 - 21 Mart 2018, cilt.53, ss.272-273
Is post-transplant albumin a predictor of early transplant complications?
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portekiz, 18 - 21 Mart 2018, cilt.53, ss.344-345
BCNU-EAM vs non-BCNU alternative alkylator -EAM conditioning regimens for autologous stem cell transplantation in lymphoma patients
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portekiz, 18 - 21 Mart 2018, cilt.53, ss.256-257
Impact of Hepatitis B Core Antibody Seopositivity on the Liver Function Tests after Autologous Hematopoietic Stem Cell Transplantation For Multiple Myeloma
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portekiz, 18 - 21 Mart 2018, cilt.53, ss.338 
The Outcome of Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation for Isolated CD4 (+) T-cell Deficiency with Interleukin-2 Inducible T-cell Kinase (ITK) Gene Defect
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portekiz, 18 - 21 Mart 2018, cilt.53, ss.533-534
Donor lymphocyte infusion after salvage chemotherapy in relapsed acute myeloblastic leukemia patients after allogeneic stem cell transplantation
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portekiz, 18 - 21 Mart 2018, cilt.53, ss.161-162
Ruxolitinib in steroid refractory GVHD treatment: single center experience
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portekiz, 18 - 21 Mart 2018, cilt.53, ss.448-449
Age is Not an Important Factor for Autologous Peripheral Hematopoietic Stem Cell Mobilization and Collection in Patients with Multiple Myeloma
Blood and Marrow Transplantion Tandem Meetings of the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR) / American-Society-for-Blood-and-Marrow-Transplantation (ASBMT), Utah, Amerika Birleşik Devletleri, 21 - 25 Şubat 2018, cilt.24
Long-Term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-Center Real-Life Experience
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, Amerika Birleşik Devletleri, 9 - 12 Aralık 2017, cilt.130
Dilemma-High Response Rates Vs High Toxicity: Autologous Stem Cell Transplantation for Lymphoma
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, Amerika Birleşik Devletleri, 9 - 12 Aralık 2017, cilt.130
Age Is Not Important for Autologous Peripheral Hematopoietic Stem Cell Transplantation in Multiple Myeloma
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, Amerika Birleşik Devletleri, 9 - 12 Aralık 2017, cilt.130
Prospective analysis of BK viremia: increases hemorrhagic cystitis (HC) incidence in allogeneic hematopoietic stem cell transplantation (Allo-HSCT)
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, Fransa, 26 - 29 Mart 2017, cilt.52
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in advanced age adults: is it possible to transplant safely?
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, Fransa, 26 - 29 Mart 2017, cilt.52
A Biosimiliar G-CSF filgrastim is as effective as a reference drug however itis not as cost effectiveas it supposed to be and by the way no impact on the health care system
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, Fransa, 26 - 29 Mart 2017, cilt.52
Large unstained cell percentage as a predictor of efficacious peripheral stem cell mobilization in autologous stem cell transplantation
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, Fransa, 26 - 29 Mart 2017, cilt.52
Peripheral blood stem cell mobilization and collection from elderly patients (>= 65 years) with multiple myeloma: A single center experience
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, Fransa, 26 - 29 Mart 2017, cilt.52
HLA C1/C1 homozygosity decreases relapse rate after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) in acute myeloid leukemia (AML) patients
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, Fransa, 26 - 29 Mart 2017, cilt.52
Herpes simplex virus (HSV) infection in patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT)
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, Fransa, 26 - 29 Mart 2017, cilt.52
The outcome of haploidentical hematopoietic cell transplantations
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, Fransa, 26 - 29 Mart 2017, cilt.52
Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of Turkish Hematology Research and Education Group (ThREG)
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, Fransa, 26 - 29 Mart 2017, cilt.52
The effect of donor Epstein-Barr virus (EBV) seropositivity on graft versus host disease (GVHD) in allogeneic hematopoietic stem cell transplantation (Allo-HSCT)
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, Fransa, 26 - 29 Mart 2017, cilt.52
Evaluating peritransplant albumin decline as a predictor of acute graft versus host disease
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, Fransa, 26 - 29 Mart 2017, cilt.52
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA: SINGLE CENTER EXPERIENCE
22nd Congress of the European-Hematology-Association, Madrid, İspanya, 22 - 25 Haziran 2017, cilt.102, ss.865
IS IT POSSIBLE TO DIAGNOSE LOW RISK MYELODYSPLASTIC SYNDROME (MDS) BY FLOW CYTOMETRY?
21st Congress of the European-Hematology-Association, Copenhagen, Danimarka, 9 - 12 Haziran 2016, cilt.101, ss.506
CD34 POSITIVE CELL COUNT DETECTED BY MULTI-COLOR FLOW CYTOMETRY (MFC) AFTER FIRST INDUCTION THERAPY IN ACUTE MYELOID LEUKEMIA (AML) EFFECTS ON SURVIVAL AND RELAPSE
21st Congress of the European-Hematology-Association, Copenhagen, Danimarka, 9 - 12 Haziran 2016, cilt.101, ss.682
MANAGEMENT AND OUTCOME OF CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): PRE AND POST TRANSPLANT
21st Congress of the European-Hematology-Association, Copenhagen, Danimarka, 9 - 12 Haziran 2016, cilt.101, ss.356
BEING OVERWEIGHT/OBESE PRIOR TO ALLOJENEIK HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT) IS RELATED TO BETTER OVERALL SURVIVAL (OS) AND DECREASED NON-RELASE MORTALITY
21st Congress of the European-Hematology-Association, Copenhagen, Danimarka, 9 - 12 Haziran 2016, cilt.101, ss.637
OUR APPROACH TO HAIRY CELL LEUKEMIA (HCL): 31 YEARS OF EXPERIENCE
21st Congress of the European-Hematology-Association, Copenhagen, Danimarka, 9 - 12 Haziran 2016, cilt.101, ss.442
EXTRACORPOREAL PHOTOPHERESIS: SAFE AND EFFECTIVE FOR THE TREATMENT OF MYCOSIS FUNGOIDES
21st Congress of the European-Hematology-Association, Copenhagen, Danimarka, 9 - 12 Haziran 2016, cilt.101, ss.393-394
THROMBOSIS IN PAROXYSMAL NOCTURNAL HEMOGLOBULINURIA PATIENTS: SINGLE CENTER EXPERIENCE
24th Biennial International Congress on Thrombosis / EMLTD Congress, İstanbul, Türkiye, 4 - 07 Mayıs 2016, cilt.141
ARE AGE AND JAK2V617F MUTATION RELATED TO THROMBOSIS IN CHRONIC MYELOPROLIFERATIVE DISEASES?
24th Biennial International Congress on Thrombosis / EMLTD Congress, İstanbul, Türkiye, 4 - 07 Mayıs 2016, cilt.141
THERAPEUTIC PLASMA EXCHANGE FOR THROMBOTIC MICROANGIOPATHY
24th Biennial International Congress on Thrombosis / EMLTD Congress, İstanbul, Türkiye, 4 - 07 Mayıs 2016, cilt.141
THERAPEUTIC THROMBOCYTAPHERESIS: HIGHER PLATELET COUNTS SHOULD MATTER
24th Biennial International Congress on Thrombosis / EMLTD Congress, İstanbul, Türkiye, 4 - 07 Mayıs 2016, cilt.141
Regrafting For Primary and Secondary Graft Failure
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, İspanya, 3 - 06 Nisan 2016, cilt.51
Efficacy of High Dose Corticosteroid Premedication for the Prevention of Anti-thymocyte Globulin Related Side Effects
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, İspanya, 3 - 06 Nisan 2016, cilt.51
Effect of Cytomegalovirus Reactivation on Prognosis After Allogeneic Transplantation for Acute Leukemia with Active Disease Conditioned with a Sequential Regimen and Anti-Thymocyte Globulin
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, İspanya, 3 - 06 Nisan 2016, cilt.51
Clinical Characteristics and Frequency of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, İspanya, 3 - 06 Nisan 2016, cilt.51
Seroprevalence for Toxoplasma Gondii in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126
The Effect of Pre-Transplant Psychological Well-Being on Hematological Reconstitution Following Autologous Stem Cell Transplantation in Multiple Myeloma Patients
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126
Comparison of Two Different Doses of Corticosteroid Premedication for Antithymocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126
Extracorporeal Photopheresis for the Treatment of Mycosis Fungoides
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126
Positive Impact of Chronic Graft-Versus Host Disease on Survival in 928 Allogeneic Hematopoietic Stem Cell Transplant Recipients
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126
Upper and Lower Respiratory Tract Infections By Respiratory Viruses in Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126
Is Initial CD3+T Cell Dose in Donor Lymphocyte Infusion for Relapsed Hematological Malignancies a Prognostic Determinant?
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126
POST TRANSPLANT ERYTHROCYTOSIS IN ELEVEN CASES
20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.616
SUBCUTANEOUS BORTEZOMIB IS AS EFFECTIVE AND LESS NEUROTOXIC THAN INTRAVENOUS BORTEZOMIB: ANKARA University EXPERIENCE
20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.740-741
ALLOGENEIC STEM-CELL TRANSPLANTATION FOR ADVANCED MYCOSIS FUNGOIDES/SEZARY SYNDROME
20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.662-663
FERTILITY IN OUR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS: RESULTS FOR 23 YEARS OF EXPERIENCE
20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.602
Extramedullary Relapse of Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT): A Single Center Experience
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50
Is it possible to overcome the catastrophic complications of Hematopoietic Stem Cell Transplantation (HSCT) using Plasma Exchange (PE)?: A Single Center's Experience
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, ss.5581-5582
Age, Cytopenia at Diagnosis and History of Hypertension are associated with Stem Cell Mobilization Failures Among Patients with Multiple Myeloma
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50
Generic (Bioequivalent) Melphalan Has Similar Efficacy and Toxicity but Lower Cost in the Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50
Erythrocytosis following allogeneic hematopoietic stem cell transplantation in six cases
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50
Impact of Pre-transplant Serum Ferritin on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50
Different Doses of Anti-Thymocyte Globulin (ATG) in the Conditioning Regimen for Allogeneic Hematopoetic Stem Cell Transplantation
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015
Allogeneic Stem-Cell Transplantation for Hodgkin and non-Hodgkin Lymphoma: Single-center experience
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, ss.5619
Allogeneic Stem-Cell Transplantation for advanced mycosis fungoides/Sezary syndrome: Single-center experience
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, ss.5618-5619
Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria: Single Centre Experience
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50
Is there an optimum CD3+T cell dose for donor lymphocyte infusion?
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, ss.5598
Upgrade Of FDG-PET Response Following Autologous Stem Cell Transplantation Is Associated With Better Progression Free Survival Among Patients With Multiple Myeloma
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50
Upper and lower respiratory tract infections by respiratory viruses in adult recipients of allogeneic hematopoeitic stem cell transplantation (Allo-HSCT): Single center
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50
The relapse in acute leukemia after the allogeneic hematopoetic stem cell transplantation: No approaches have been superior yet
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50
Prognosis of Acute Leukemia Patients with Active Disease Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015
HLA-A allele mismatch (7/8 or 9/10) is the second best option after 8/8 or 10/10 matched unrelated donors: An analysis on results from Turkish centers
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50
Autologous Stem Cell Transplantation in Elderly Patients ( >=60 years) with Myeloma or Lymphoma: Single Center Experience
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, ss.5622
Cytopenia at Diagnosis Impairs Stem Cell Mobilization Among Patients with Multiple Myeloma
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124
Is the Chronic Myeloproliferative Disease Prognosis Really Different in Geriatric Patients?
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124
Do FMS-like Tyrosine Kinase 3 and Nucleophospmin 1 Gene Mutations Really Effect Survival in Acute Myeloid Leukemia ?
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124
Fertility in Our Allogeneic Hematopoietic Stem Cell Transplant Patients
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124
Treatment Approaches in Acute Leukemia Patients Relapsing Following Allogeneic Hematopoietic Stem Cell Transplantation
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124
Is R-CODOX-M/IVAC Inferior to Other Regimens in Burkitt's Lymphoma: A Single Center Experience
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124
Favorable Treatment Alternative for Primary Central Nervous System Lymphoma: Combined Chemotherapy Regimen Consisting of High-Dose Methotrexate, Rituximab and Cytosine-Arabinoside
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124
Unique presentation of refractory leukaemic cutaneous CD3/T-cell receptor-negative phenotype T-cell lymphoma with complete remission after allogeneic stem cell transplantation
15th World Congress on Cancers of the Skin, Edinburgh, Saint Helena, 3 - 06 Eylül 2014, cilt.171, ss.12
Unique presentation of refractory leukaemic cutaneous CD3/T-cell receptor-negative phenotype T-cell lymphoma with complete remission after allogeneic stem cell transplantation
15th World Congress on Cancers of the Skin, Edinburgh, Saint Helena, 3 - 06 Eylül 2014, cilt.171
BRENTUXIMAB VEDOTIN FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: EXPERIENCE IN TURKEY
19th Congress of the European-Hematology-Association, Milan, İtalya, 12 - 15 Haziran 2014, cilt.99, ss.675-676
STEM CELL MOBILIZATION IN ELDERLY MULTIPLE MYELOMA PATIENTS: SINGLE CENTER EXPERIENCE
19th Congress of the European-Hematology-Association, Milan, İtalya, 12 - 15 Haziran 2014, cilt.99, ss.721
RISK FACTORS FOR THE DEVELOPMENT OF INVASIVE INVASIVE FUNGAL INFECTION IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Milan, İtalya, 30 Mart - 02 Nisan 2014, cilt.49
EXTRACORPOREAL PHOTOAPHERESIS IN GRAFT VERSUS HOST DISEASE
40th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Milan, İtalya, 30 Mart - 02 Nisan 2014, cilt.49
Tumor necrosis factor inhibitors and acute leukemia in two cases.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31
Aldehyde hydrogenase activity in mobilized peripheral stem cell products and its relationship with engraftment
39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, Kanada, 7 - 10 Nisan 2013, cilt.48
Sequential chemotherapy plus allogeneic haematopoetic stem cell transplantation: is it a good alternative as salvage treatment for heavily pretreated patients with leukaemia?
39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, Kanada, 7 - 10 Nisan 2013, cilt.48
Graft content and engraftment relationship in allogeneic bone marrow transplantation
39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, Kanada, 7 - 10 Nisan 2013, cilt.48
The effect of cyclophosphamide with bortezomib as the mobilisation regimen on the graft quality and response of disease in multiple myeloma
38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), Geneva, İsviçre, 1 - 04 Nisan 2012, cilt.47
Oral cavity chronic-graft-versus host disease after allogeneic haematopoietic stem cell transplantation
38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), Geneva, İsviçre, 1 - 04 Nisan 2012, cilt.47
Peripheral stem cell apheresis in multiple myeloma in the era of new agents
37th European Group for Bone and Marrow Transplantation/27th Meeting of the EBMT Nurses Group/10th Meeting of the EBMT Management Group, Paris, Fransa, 3 - 06 Nisan 2011, cilt.46
Invasive fungal infections during a construction period
37th European Group for Bone and Marrow Transplantation/27th Meeting of the EBMT Nurses Group/10th Meeting of the EBMT Management Group, Paris, Fransa, 3 - 06 Nisan 2011, cilt.46
The role of second allogeneic haematopoietic cell transplantation on relapse of haematological diseases
37th European Group for Bone and Marrow Transplantation/27th Meeting of the EBMT Nurses Group/10th Meeting of the EBMT Management Group, Paris, Fransa, 3 - 06 Nisan 2011, cilt.46
Comparison of two different chemotherapy regimens for peripheral blood stem cell mobilization in lymphoma
36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting, Vienna, Avusturya, 21 - 24 Mart 2010, cilt.45
Allogeneic haematopoietic cell transplantation in paroxysmal nocturnal haemoglobinuria: a therapeutic dilemma from start to discharge
36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting, Vienna, Avusturya, 21 - 24 Mart 2010, cilt.45
Bronchiolitis obliterans after allogeneic haematopoietic cell transplantation: inpredictable and fatal
36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting, Vienna, Avusturya, 21 - 24 Mart 2010, cilt.45
Significance of serial chimerism analysis in allogeneic haematopoietic cell transplantation for bone marrow failure: do stable mixed chimerism matter?
36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting, Vienna, Avusturya, 21 - 24 Mart 2010, cilt.45
The handheld dermatoscope as a nail-fold capillaroscopic instrument in sclerodermoid graft-versus-host disease
36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting, Vienna, Avusturya, 21 - 24 Mart 2010, cilt.45
Allogeneic haematopoetic cell transplantation in hepatitis B surface antigen positive recipients
36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting, Vienna, Avusturya, 21 - 24 Mart 2010, cilt.45
The effect of rituximab in first line therapy to results of autologus haematopoietic stem cell transplantation in relapsed non-Hodgkin's lymphoma patients
35th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Goteborg, İsveç, 29 Mart - 01 Nisan 2009, cilt.43
FACTORS INVOLVED IN RESPONSE TO THALIDOMIDE IN MYELODYSPLASTIC SYNDROME: IMPACT OF HLA AND PROGNOSTIC FACTORS
13th Congress of the European-Hematology-Association, Copenhagen, Danimarka, 12 - 15 Haziran 2008, cilt.93, ss.406-407
RESULTS OF EMA THERAPY IN RELAPSED AND REFRACTORY ACUTE MYELOBLASTIC LEUKEMIA
13th Congress of the European-Hematology-Association, Copenhagen, Danimarka, 12 - 15 Haziran 2008, cilt.93, ss.413-414
Allogeneic haematopetic cell transplantation in elderly patients: validation of survival according to Sorror comorbidity index
34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group, Florence, İtalya, 30 Mart - 02 Nisan 2008, cilt.41
The relation between the disparities of short tandem repeats between donor-recipient pair and the allogeneic haematopoietic cell transplantation outcome
34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group, Florence, İtalya, 30 Mart - 02 Nisan 2008, cilt.41
Response to induction, early mobilisation and pre-autologous transplant use of bortezomib and/or thalidomide prolong progression free and/or overall survival in myeloma
34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group, Florence, İtalya, 30 Mart - 02 Nisan 2008, cilt.41
The presence of thrombophilia and the development of thromboembolic complications in allogeneic haematopoietic cell transplantation
34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group, Florence, İtalya, 30 Mart - 02 Nisan 2008, cilt.41
Do the febrile neutropenic episodes during mobilisation have any effect on autologous stem cell collection yield in patients with myeloma and lymphoma?
34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group, Florence, İtalya, 30 Mart - 02 Nisan 2008, cilt.41
The impact of disparity in short tandem repeats (STRS) analysis on the outcome of allogeneic hematopoietic cell transplantation (allo-HCT) from HLA-identical sibling donors
12th Congress of the European-Hematology-Association, Vienna, Avusturya, 7 - 10 Haziran 2007, cilt.92, ss.517
Treatment of relapse after allogeneic stem cell transplantation in CML patients: Imatinib only vs imatinib&DLI
12th Congress of the European-Hematology-Association, Vienna, Avusturya, 7 - 10 Haziran 2007, cilt.92, ss.487
Is there any effect of invasive fungal infection on the outcome of hematopoetic stem cell transplantation
12th Congress of the European-Hematology-Association, Vienna, Avusturya, 7 - 10 Haziran 2007, cilt.92, ss.390-391
Case matched comparison for analysing the impact of regimen intensity of allogeneic haematopoietic cell transplantation in chronic myeloid leukaemia
33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Lyon, Fransa, 25 - 28 Mart 2007, cilt.39
The impact of disparity in short tandem repeats analysis on the outcome of allogeneic haematopoietic cell transplantation from HLA-identical sibling donors
33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Lyon, Fransa, 25 - 28 Mart 2007, cilt.39
Impact of histopathological subtype of cutaneous chronic GvHD on alloHSCT outcome: Iichenoid versus scleradermoid
33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Lyon, Fransa, 25 - 28 Mart 2007, cilt.39
Treatment of relapse after allogeneic stem cell transplantation in CML patients: imatinib only versus imatinib&DLI
33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Lyon, Fransa, 25 - 28 Mart 2007, cilt.39
Is there any benefit of secondary approaches for stem cell (auto-PBSC) collection in poor mobilising myeloma and lymphoma patients?
33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Lyon, Fransa, 25 - 28 Mart 2007, cilt.39
The impact of pretransplant imatinib use in allogeneic haematopoietic cell transplantation for CML: a single-centre comparative analysis
33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Lyon, Fransa, 25 - 28 Mart 2007, cilt.39
Relationship between the mucositis seen after the allogeneic haematopoietic stem cell transplantation and the human leucocyte antigen types
33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Lyon, Fransa, 25 - 28 Mart 2007, cilt.39
Time intervals preceeding autologous stem cell transplantation in multiple myeloma patients: a single-centre intent to transplant analysis
33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Lyon, Fransa, 25 - 28 Mart 2007, cilt.39
Allogeneic hematopoietic cell transplantation in imatinib era: A single center comparative analysis of imatinib receiving patients to imatinib naive patients
Tandem BMT Meeting 2007, Colorado, Amerika Birleşik Devletleri, 8 - 12 Şubat 2007, cilt.13, ss.100-101
Catheter infections in stem cell transplant patients
31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group, Prague, Çek Cumhuriyeti, 20 - 23 Mart 2005, cilt.35
Transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy: safety, efficacy and outcome
31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group, Prague, Çek Cumhuriyeti, 20 - 23 Mart 2005, cilt.35
Allogeneic haematopoietic cell transplantation in acute myeloblastic laeukemia: Ibni Sina experience (1989-2004)
31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group, Prague, Çek Cumhuriyeti, 20 - 23 Mart 2005, cilt.35
The effect of a nationwide antibiotic restriction policy on antibiotic usage in a stem cell transplantation unit in Turkey
31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group, Prague, Çek Cumhuriyeti, 20 - 23 Mart 2005, cilt.35
The comparison of myeloablative versus reduced intensity conditioning regimen in ABO mismatched allogeneic hematopoietic cell transplantation.
46th Annual Meeting of the American-Society-of-Hematology, California, Amerika Birleşik Devletleri, 4 - 07 Aralık 2004, cilt.104
The comparison of two different conditioning regimens, myeloablative versus reduced intensive, in ABO mismatched allogeneic haematopoietic stem cell transplantation
30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, İspanya, 28 - 31 Mart 2004, cilt.33
Does donor/recipient parity have any impact on graft-versus-host disease? The results of a single-centre retrospective multivariate analysis
30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, İspanya, 28 - 31 Mart 2004, cilt.33
The outcome of patients with an identified HLA identical sibling donor: impact of transplantation rate on early transplant outcome
30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, İspanya, 28 - 31 Mart 2004, cilt.33
Factors influencing the outcome of HLA-identical sibling transplants for chronic myeloid leukaemia: collaborative analysis from three centres in Poland and Turkey
30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, İspanya, 28 - 31 Mart 2004, cilt.33
High-dose therapy is given to multiple myeloma patients with similar clinical characteristics to those in conventional chemotherapy and improves survival in multiple myeloma: a retrospective analysis from a single centre
30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, İspanya, 28 - 31 Mart 2004, cilt.33
Occurrence of cytomegalovirus infection and/or viraemia shortens overall survival
30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, İspanya, 28 - 31 Mart 2004, cilt.33
The effect of hepatitis B virus status of the donor on the hepatitis B virus serology of the recipient after allogeneic hematopoietic cell transplantation
38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Türkiye, 29 Mart - 01 Nisan 2003, cilt.38, ss.146
Comparison of three conditioning regimens used in high-dose therapy of malign lymphomas: CBV-ICE-CTM
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Türkiye, 23 - 26 Mart 2003, cilt.31
The relation between T-helper subsets and the risk of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Türkiye, 23 - 26 Mart 2003, cilt.31
The effect of mycophenolate mofetil in steroid refractory or dependent chronic graft-versus-host disease
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Türkiye, 23 - 26 Mart 2003, cilt.31
Kitap & Kitap Bölümleri
Metrikler
BM Sürdürülebilir Kalkınma Amaçları
